We are delighted to announce that Lidings has updated The Pharma Legal Handbook: Russia - practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.
On May 14, in Moscow, Lidings held PHARMAtory - a traditional event for representatives of the pharmaceutical industry, where we discuss the most topical issues of the industry. This year the meeting took place during the Semashko Russian Pharmaceutical Forum in St. Petersburg (May 14 - 15).
Lidings experts have authored the The Pharma Legal Handbook — practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia. The Handbook covers major issues linked to regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents in Russia and is a must-have for any company operating in the country or looking to enter the market.
Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2024 the firm is ranked among the TOP leading legal advisors in Russia.
On April 11, 2024, in Moscow, the annual Pravo.ru conference "Pharmaceuticals – 2024: Legal Issues" will take place. Lidings lawyers traditionally take an active part in the event’s program.
As a strategic partner of the conference, we have endeavored to make the program as comprehensive and useful as possible. Together with experts from the pharmaceutical industry and legal experts, we will discuss current issues in industry regulation, legislative changes, market access, government procurement, and distribution. We will also touch upon marketing and promotion issues, as well as discuss strategies for protecting intellectual property.
Lidings invites to take part in scientific-practical conference "DESIGN: 9 Landmark Cases". The event will take place online from 2 PM to 5 PM Moscow time.
On 4 November 2023 the decree of the Ministry of Industry and Trade No. 2701 dated 21 July 2023, which approved a new list of goods for parallel import and recognized the decree of the Ministry of Industry and Trade No. 1532 dated 19 April 2022 and all the amending decrees as null and void, comes into force.
By its Ruling of 25.09.2023 in case No. A40-185112/2022, the Ninth Commercial Court of Appeal ordered the pharmaceutical company Vertex, the right holder of a series of patents for the drug Trikafta (INN: Ivacaftor+Tezacaftor+Elexacaftor, Ivacaftor), to grant a simple (non-exclusive) license to the Russian pharmaceutical company MIK under Article 1362(1) of the Russian Civil Code (insufficient use of patents).
Lidings’ IP team has successfully secured recognition of the Doppelherz brand as a well-known trademark specifically for dietary supplements, setting a valuable precedent. The interests of the client, the German pharmaceutical company Queisser Pharma, which owns the brand, were represented by Boris Malakhov, Partner, and Vladislav Ryabov, Senior Associate.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.